Overactive Bladder Linked to Prostate Cancer ADT
Compared with men receiving androgen deprivation therapy for prostate cancer, healthy men had a 98% decreased risk of overactive bladder, study finds.
OAB
OAB Symptoms Eased With Intravesical Botulinum Toxin
In a small trial, patients receiving 300 U and 500 U of intravesical abobotulinumtoxin A experienced reductions in nocturia episodes at 12 and 24 weeks.
Nocturia in Review
Recent studies provide insight into the epidemiology of the condition and its associated complications.
Next post in Overactive Bladder (OAB)
